Cargando…

Clinical efficacy of convalescent plasma therapy on treating COVID‐19 patients: Evidence from matched study and a meta‐analysis

Detalles Bibliográficos
Autores principales:	Jiang, Weijun, Li, Weiwei, Xiong, Lei, Wu, Qiuyue, Wu, Jian, He, Bangshun, Shen, Jiawei, Pang, Rongrong, Luo, Tao, Guo, Yanju, Yang, Yang, Han, Ying, Dai, Wei, Zhu, Peiran, Xia, Xinyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752155/ https://www.ncbi.nlm.nih.gov/pubmed/33377664 http://dx.doi.org/10.1002/ctm2.259

Ejemplares similares

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
por: Wu, Jian, et al.
Publicado: (2021)

Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation
por: Lin, Jie, et al.
Publicado: (2021)

Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis
por: Jiang, Weijun, et al.
Publicado: (2021)

Tumor biomarkers predict clinical outcome of COVID-19 patients
por: He, Bangshun, et al.
Publicado: (2020)

The paradoxical problem with COVID-19 ocular infection: Moderate clinical manifestation and potential infection risk
por: Shen, Jiawei, et al.
Publicado: (2021)

3044 Cases reveal important prognosis signatures of COVID-19 patients
por: Qin, Shijie, et al.
Publicado: (2021)

Predictive value of GGN and CAG repeat polymorphisms of androgen receptors in testicular cancer: a meta-analysis
por: Jiang, Weijun, et al.
Publicado: (2016)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

The susceptibility of FSHB -211G > T and FSHR G-29A, 919A > G, 2039A > G polymorphisms to men infertility: an association study and meta-analysis
por: Wu, Qiuyue, et al.
Publicado: (2017)

Polymorphisms of protamine genes contribute to male infertility susceptibility in the Chinese Han population
por: Jiang, Weijun, et al.
Publicado: (2017)

Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
por: Franchini, Massimo, et al.
Publicado: (2022)

Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
por: Zhou, Cindy Ke, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19: clinical experience and efficacy
por: Pei, Shiyao, et al.
Publicado: (2021)

A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021)

Convalescent plasma to treat COVID-19: Following the Argentinian lead
por: Tiberghien, Pierre, et al.
Publicado: (2021)

Hyperhomocysteinaemia in rats is associated with erectile dysfunction by impairing endothelial nitric oxide synthase activity
por: Jiang, Weijun, et al.
Publicado: (2016)

Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity
por: Dai, Wei, et al.
Publicado: (2022)

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
por: Murphy, Michael, et al.
Publicado: (2020)

Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation
por: Hashim, H.T.
Publicado: (2020)

Convalescent Plasma – Is it Useful for Treating SARS Co-V2 infection?
por: Ranganathan, Sudha, et al.
Publicado: (2020)

Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
por: Rahimi-Levene, Naomi, et al.
Publicado: (2022)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Evidence-based dosing of convalescent plasma for COVID-19 in future trials
por: Rijnders, Bart J.A., et al.
Publicado: (2022)

Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020)

The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study
por: Pan, Chun, et al.
Publicado: (2022)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
por: Zhang, Libo, et al.
Publicado: (2020)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
por: Xia, Xinyi, et al.
Publicado: (2020)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
por: Klassen, Stephen A., et al.
Publicado: (2021)

Exosomes derived from plasma: promising immunomodulatory agents for promoting angiogenesis to treat radiation-induced vascular dysfunction
por: Li, Yanxi, et al.
Publicado: (2021)

Scarlatina Treated with Convalescent Serum
Publicado: (1914)

549. Clinical Characteristics and Outcomes of Patients with COVID-19 treated with Convalescent Plasma in Miami, Florida
por: Anjan, Shweta, et al.
Publicado: (2020)

Clinical and immunological characteristics in COVID-19 convalescent patients
por: Su, Zhiying, et al.
Publicado: (2021)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1gipihlpget9fi4mklcr186h98